This Project Grant award from the National Cancer Institute (CFDA 93.398 - Cancer Research Manpower) provides $173,997 to Duke University to develop and test a mindfulness-based intervention called NITE2DAY+ to improve sleep quality, fatigue, distress, and pain symptoms in hematologic cancer patients during and after inpatient treatment. The 5-year study will assess the feasibility, acceptability, engagement, and preliminary outcomes of the NITE2DAY+ intervention, which combines self-paced mobile app-based mindfulness meditations, sleep education, and behavioral strategies for inpatient and outpatient settings. The goal is to establish a comprehensive symptom management protocol that can be integrated across the challenging inpatient to outpatient cancer care continuum faced by this patient population. The award will also provide Dr. Fisher with advanced training and mentorship in behavioral sleep and cancer symptom management research, intervention development, and randomized trial design.
Generated 1/28/25, 9:35 AM